Pharmacy benefit managers Express Scripts and Medco Health Solutions are in talks with officials at the Federal Trade Commission to address issues raised by the agency about their proposed $29 billion merger, but no final decision by the FTC is imminent, according to people familiar with the matter.
FTC decision on Medco-Express Scripts deal isn't imminent
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.